Hilal Özakıncı

10PUBLICATIONS
91CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 26, 2026
ISL1: A Novel Neuroendocrine Subtype in Small Cell Lung Cancer Predicts Durable Response to Lurbinectedin.

Misty D Shields, Katherine G Minton, Hilal Ozakinci

|Jan 21, 2025
In Situ RAS:RAF Binding Correlates with Response to KRASG12C Inhibitors in KRASG12C-Mutant Non-Small Cell Lung Cancer.

Ryoji Kato, Hitendra S Solanki, Hilal Ozakinci

|Nov 03, 2024
Combination of grade and spread through air spaces (STAS) predicts recurrence in early stage lung adenocarcinoma: a retrospective cohort study.

Betul Bahar Isgir, Gokhan Kocaman, Yusuf Kahya

|Mar 28, 2024
Oncological results in primary and secondary malignant chest wall tumors.

Gökhan Kocaman, Yusuf Kahya, Buse Mine Konuk Balcı

|Feb 01, 2023
Comparıson of the effect of the autogenıc and xenogenıc use of platelet-rıch plasma on rabbıt chondrocutaneous composıte graft survıval.

Hande Akdeniz, Koray Gursoy, Gokay Baykara

|Dec 20, 2021
HER2 Amplification by Next-Generation Sequencing in Lung Carcinoma: A Comparison of NGS Amplified and Non-amplified Cases by Immunohistochemistry and In Situ Hybridization

Hale Kıvrak, Hilal Özakıncı, Duru Karasoy

Pageof 2

Frequent Collaborators

3 joint publications

Aycan Yuksel

3 joint publications

Dilek Karadogan

3 joint publications

Canan Gunduz Gurkan

3 joint publications

Fatma Tokgöz Akyıl